269 related articles for article (PubMed ID: 12809484)
1. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
[TBL] [Abstract][Full Text] [Related]
2. Multiple activation steps of the N-formyl peptide receptor.
Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins.
Key TA; Vines CM; Wagener BM; Gurevich VV; Sklar LA; Prossnitz ER
Traffic; 2005 Feb; 6(2):87-99. PubMed ID: 15634210
[TBL] [Abstract][Full Text] [Related]
4. Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins.
Key TA; Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
J Biol Chem; 2001 Dec; 276(52):49204-12. PubMed ID: 11598142
[TBL] [Abstract][Full Text] [Related]
5. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
6. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
Bennett TA; Maestas DC; Prossnitz ER
J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
[TBL] [Abstract][Full Text] [Related]
7. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
[TBL] [Abstract][Full Text] [Related]
8. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
9. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells.
Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
J Immunol; 1993 Nov; 151(10):5704-15. PubMed ID: 8228256
[TBL] [Abstract][Full Text] [Related]
10. N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity.
Key TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
J Biol Chem; 2003 Feb; 278(6):4041-7. PubMed ID: 12424254
[TBL] [Abstract][Full Text] [Related]
11. Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.
Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
J Biol Chem; 2001 Dec; 276(52):49195-203. PubMed ID: 11602585
[TBL] [Abstract][Full Text] [Related]
12. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
[TBL] [Abstract][Full Text] [Related]
13. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.
Gazi L; Nickolls SA; Strange PG
Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378
[TBL] [Abstract][Full Text] [Related]
14. Arrestin variants display differential binding characteristics for the phosphorylated N-formyl peptide receptor carboxyl terminus.
Potter RM; Key TA; Gurevich VV; Sklar LA; Prossnitz ER
J Biol Chem; 2002 Mar; 277(11):8970-8. PubMed ID: 11777932
[TBL] [Abstract][Full Text] [Related]
15. The uncoupled state of the human formyl peptide receptor.
Gilbert TL; Prossnitz ER; Sklar LA
J Recept Signal Transduct Res; 1999; 19(1-4):327-40. PubMed ID: 10071768
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
[TBL] [Abstract][Full Text] [Related]
17. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
18. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
19. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
Posner RG; Fay SP; Domalewski MD; Sklar LA
Mol Pharmacol; 1994 Jan; 45(1):65-73. PubMed ID: 8302282
[TBL] [Abstract][Full Text] [Related]
20. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms.
Gilbert TL; Bennett TA; Maestas DC; Cimino DF; Prossnitz ER
Biochemistry; 2001 Mar; 40(12):3467-75. PubMed ID: 11297412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
